Aethlon Medical Inc. of San Diego has formed a relationship with Kentucky Bioprocessing to establish processes that will support Aethlon’s Hemopurifier®, a medical device that absorbs viruses and immunosuppressive particles from the bloodstream. “The relationship with Kentucky Bioprocessing represents an important step towards establishing the long-term commercial feasibility of our Hemopurifier®, said Aethlon Medical CEO Jim Joyce. “Beyond a significant cost reduction of our affinity agents, the relationship offers large-yield production potential in time frames that could improve our response capability against viral outbreaks, including unforeseen bioterror and pandemic threats.”
Add Comment